Arcturus Therapeutics Holdings Inc.

Healthcare · Biotechnology · United States

Last price 11.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 313.51M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In additi...